Home » Archive

Articles in the Open Trials Category

Closed Trials »

[19 Aug 2009 | Comments Off | ]

What is Lymphoma?

Lymphoma is the most common malignant cancer treated in veterinary oncology. Lymphoma is a cancer of lymphocytes, which are white blood cells that are part of the immune system and reside in the lymph nodes, bone marrow, and spleen. In most cases, lymphoma is thought of as a disseminated disease where the malignant lymphocytes exist in many tissues throughout the body.

How is Canine Lymphoma Treated?

Multi-agent chemotherapy is the current standard option for treatment of lymphoma. Canine lymphoma is one of …

Closed Trials »

[21 May 2009 | Comments Off | ]

Summary: This prospective study evaluated the effects of thrombospondin-I peptides in canine patients with various cancers. No adverse effects were noted. Approximately 40% of these patients showed improvements identified by stable disease unexpected for the biology of that given cancer, partial remissions, or complete remissions. Abstract submitted to the Amercian Society of Clinical Oncology Annual Meeting 2002

Closed Trials »

[21 May 2009 | Comments Off | ]

Summary: This prospective study evaluated the effects of thrombospondin-1 peptides in 10 feline patients with various cancers. No objective response was seen in these patients. No adverse effects were noted.